GLYBURIDE-INDUCED CHOLESTATIC HEPATITIS AND LIVER-FAILURE - CASE-REPORT AND REVIEW OF THE LITERATURE

被引：0

作者：

VANBASTEN, JP ^{[1
]}

VANHOEK, B ^{[1
]}

ZEIJEN, R ^{[1
]}

STOCKBRUGGER, R ^{[1
]}

机构：

[1] UNIV LIMBURG HOSP,DEPT INTERNAL MED,DIV GASTROENTEROL HEPATOL,P DEBYELAAN 25,6202 AZ MAASTRICHT,NETHERLANDS

来源：

NETHERLANDS JOURNAL OF MEDICINE | 1992年 / 40卷 / 5-6期

关键词：

GLYBURIDE; SULFONYLUREA DERIVATIVES; CHOLESTASIS; HEPATITIS; DRUG-INDUCED LIVER DISEASE; LIVER FAILURE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

As sulphonylurea derivatives are used ubiquitously, the possibility that they may cause liver disease deserves attention. In contrast to the known pattern of reversible parenchymal liver disease due to sulphonylurea derivatives, we describe a fatal case of glyburide-induced cholestatic hepatitis with liver failure.

引用

页码：305 / 307

页数：3

共 19 条

[1]

ACERO D, 1981, GASTROENTEROL HEPATO, V4, P360

[2]

ALBERTIFLOR JJ, 1989, AM J GASTROENTEROL, V84, P1577

[3] OUTPATIENT DRUG-INDUCED PARENCHYMAL LIVER-DISEASE REQUIRING HOSPITALIZATION [J].